Skip to main content
. 2022 Jan 27;14(5):6331–6342. doi: 10.1021/acsami.1c19192

Figure 2.

Figure 2

Antibody responses. (A) Immunization, challenges, and sampling schedule. (B) Aichi-specific IgG levels in prime sera. (C) Aichi-specific IgG and IgG subtype levels in boost sera. (D) HAI titers in boost sera. (E–G) Aichi-specific antibody levels in mucosal washes. Data are presented as mean ± SEM (n = 5 for B–D, n = 3–4 for E–G). One-way ANOVA then Tukey’s multiple comparison tests were used for statistical significance analysis (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; ns, p > 0.05).